Replies to post #105 on Aida Pharmaceuticals (AIDA)

[PaperProphet]

Thanks. It's helpful that you can read Chinese. I'm limited to the translator on Google.

I'm sure that Jiangsu was worth the $10 million but I'm hoping its more of an immediate return even if it's a lower return rather than looking too far out in the future. Aida has a good thing going but they can kill themselves if they add too much risk.

In the meantime, the 10Q seems to indicate that the Nanwang issue is greatly alleviated with assets of $7M of Nanwang's assets being sequestered. The news on Nanwang's default was obviously the reason for the drop in Aida's share price. However the price hasn't recovered much with Aida indicating they have control of those assets. It's possible investors aren't sure whether Aida can liquidate those assets for $7M.

Hopefully the phase II results for Rh-Apo2L will be out soon.